baber/WOPTO huggingface dataset:
Patent NZ-588928-A (NZ)
Title: Changing frequency channels when acknowledgement of sent packet is not received
Inventor: SHUEY KENNETH C
IPC: H04B7/00
Filed: 2010-10-29
Abstract: A wireless mesh network and a method operating a wireless mesh network is disclosed. The wireless mesh network comprises: a central node; and a plurality of bidirectional nodes in bidirectional wireless communication with the central node. The central node comprises a transceiver configured to transmit and receive data communications using selected frequency channels of a plurality of frequency channels. The plurality of bidirectional nodes is in bidirectional wireless communication with the central node where each bidirectional node has a respective wireless communication path to the central node that is either a direct path or an indirect path through one or more intermediate bidirectional nodes serving as repeater nodes. Each bidirectional node is characterized by a number of intermediate bidirectional nodes forming a respective wireless communication path to the central node. The central node initiates a first data communication comprising a preamble from the central node to a first bidirectional node of the plurality of bidirectional nodes using a first frequency channel selected from the plurality of frequency channels and sets a receive frequency of the transceiver of the central node to a second frequency channel selected from the plurality of frequency channels. In response to the first bidirectional node receiving the first data communication, the first bidirectional node transmits an acknowledgement message to the central node using the second frequency channel. The central node retransmits the first data communication to the first bidirectional node using the second frequency channel in response to the central node failing to receive the acknowledgement message within a defined time limit.
Patent NZ-598787-A (NZ)
Title: PROCESS FOR TREATING WITH A CHEMICAL COMPOUND A BODY OF WATER USED IN AQUACULTURE AND THE BODY OF WATER is AGITATED WITH UNDERWATER EDUCTOR NOZZLES
Inventor: SKITT PAUL
IPC: A01K63/04
Filed: 2010-09-10
Abstract: 598787 Disclosed is a process for treating with at least one chemical compound a body of water comprising at least one living organism selected from fish, molluscs, crustaceans and aquatic plants. The process comprises adding the chemical compound to the body of water and agitating the water with an agitation system comprising a pump and at least one submerged outlet equipped with an eductor nozzle. The eductor nozzle comprises a nozzle part through which exits the liquid pumped through the agitation system via the pump, an eductor part through which part of the water present in the body of water to be treated is sucked, via at least one suction opening, the flow of liquid being called induced liquid, and a diffuser part in which the pumped liquid and the induced liquid are mixed and exit from the agitation system in the form of a total outlet flow. The induced liquid is drawn in the eductor part and then in the diffuser part of the eductor nozzle due to the high velocity of the pumped liquid exiting from the nozzle part of the eductor nozzle. The total outlet flow exiting the eductor nozzle is from 1.5 to 10 times greater than the pumped liquid flow rate exiting the nozzle part of the eductor nozzle.
Patent NZ-611948-A (NZ)
Title: Methods and drug products for treating alzheimer’s disease
Inventor: ROSES ALLEN D
IPC: C12Q1/68
Filed: 2012-01-09
Abstract: Disclosed is the use of from 0.5 to 9 milligrams of pioglitazone in the manufacture of a pharmaceutical formulation for treating cognitive decline in a subject in need thereof. Also disclosed is the use of from 0.5 to 9 milligrams of pioglitazone in the manufacture of a pharmaceutical formulation for treating cognitive impairment of the Alzheimer’s type in a subject. Further disclosed are methods of determining increased risk of developing cognitive impairment of the Alzheimer’s type that can be treated with from 0.5 to 9 mg pioglitazone in a human subject at a predetermined age or age range, comprising: detecting from a biological sample of the subject the rs10524523 genotype of the subject, wherein each allele of the rs10524523 genotype is assigned as: (a) short (S, less than 19 T residues); (b) long (L, 19-29 residues); or (c) very long (VL, 30 or more residues); and determining from the rs10524523 genotype whether the subject is at increased risk in developing cognitive impairment of the Alzheimer’s type at the predetermined age or age range, wherein: (1) age greater than about 62 and L,L or L,VL indicates increased risk; (2) age greater than about 62 and VL,VL does not indicate increased risk; (3) age greater than about 74 and S,L indicates increased risk; (4) age greater than about 77 and S,S indicates increased risk; and (5) age greater than about 76 and S,VL indicates increased risk.
Patent NZ-625887-A (NZ)
Title: Compositions comprising c5 and c6 monosaccharides
Inventor: KILAMBI SRINIVAS
IPC: C07H3/02
Filed: 2012-12-03
Abstract: Disclosed are compositions comprising C6 monosaccharides of varying degrees of polymerization and low levels of undesirable impurities, such as compounds containing aluminium, calcium, iron and sulfur. The compositions are processed from lignocellulosic biomass using supercritical, subcritical, and/or near critical fluid extraction.
Patent NZ-625983-A (NZ)
Title: Method for producing methyl-{ 4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridino-3-yl]pyrimidino-5-yl} methyl carbamate and its purification for use thereof as pharmaceutical substance
Inventor: SIEGEL KONRAD
IPC: C07D471/04
Filed: 2010-11-22
Abstract: Disclosed herein is a process for preparing methyl { 4,6-diamino-2-[1-(2-fluorobenzyl)-1H -pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl} methylcarbamate, the process including: cleaving 2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-[(E)-phenyldiazenyl]pyrimidine-4,6-diamine by catalytic hydrogenation; and , after filtration of the catalyst, precipitating 2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-4,5,6-pyrimidinetriamine from a C1-C4-alcohol and/or water without intermediate formation of salts; and utilising the 2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-4,5,6-pyrimidinetriamine so obtained in the preparation of methyl { 4,6-diamino-2-[1-(2-fluorobenzyl)-1H -pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl} methylcarbamate. The process further comprises purification of the crude methyl { 4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl} methylcarbamate which is dissolved in dimethyl sulphoxide and the resulting methyl { 4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl} methylcarbamate sulphinyldimethane is isolated and the dimethyl sulphoxide is removed by boiling in a pharmaceutically acceptable solvent. These compounds are suitable for use in the treatment of cardiovascular disorders and erectile dysfunction.
Patent NZ-626517-A (NZ)
Title: Push lock
Inventor: LI WANG
IPC: E05B65/44
Filed: 2010-12-06
Abstract: Disclosed is a lock for use with cupboards, sliding front panels, sliding windows or cabinets. The lock includes a structure, at least one engagement feature (42) and a button (8, 12). The structure is fixable to a first member. The first member has first and second sides separating first and second environments. The button (8, 12) is accessible from the first environment to be pushed inwardly along an axis. The pushed inwardly button (8, 12) moves the engagement feature (42) from an unlatched position, in which a second member is moveable relative to the first member, to a latched position, in which the engagement feature (42) is positioned to engage the second member to limit movement of the second member relative to the first member. The fixable structure includes first (6) and second (4) structural portions. The first structural portion (6) is positionable on the first side. The second structural portion (4) is positionable on the second side. The engagement feature (42) projects through the second structural portion (4). The first structural portion (6) and second structural portion (4) are mutually engageable to sandwich a portion of the first member between the first structural portion (6) and the second structural portion (4) to mount the lock.
Patent NZ-709295-A (NZ)
Title: Syringe pump system
Inventor: BAIER MICHAEL J
IPC: A61M5/145
Filed: 2013-12-20
Abstract: A method for discharging fluid from a syringe and for mitigating occlusion conditions includes actuating the plunger of a syringe into a barrel. The method monitors fluid pressure within the barrel of the syringe and determines that an occlusion exists when the fluid pressure exceeds a predetermined threshold. The method actuates the plunger out of the barrel by a predetermined amount in response to the detected occlusion and actuates the plunger of the syringe into the barrel until a measured fluid pressure within the barrel of the syringe exceeds another predetermined threshold. A syringe pump for administering an agent to a patient comprises a housing; a lead screw; a linear cam; a half-nut assembly having first and second half-nut arms each having a first end and a second end, wherein the second ends of the first and second half-nut arms are configured to engage with the lead screw, the first and second half-nut arms are pivotally coupled together, the first ends of the first and second half-nut arms are configured to engage with the linear cam such that actuation of the linear cam toward the half-nut assembly causes the first ends of the first and second half-nut arms to pivotally approach each other, and the second ends of the first and second half-nut arms each includes threads configured to engage the lead screw when the first ends of the first and second half-nut arms approach each other caused by actuation of the linear cam; and a plunger head assembly coupled to said half-nut assembly and operative to drive a plunger of a syringe into a barrel of said syringe.
Patent NZ-711230-A (NZ)
Title: An implant having expandable surface regions
Inventor: JOHN ARTHUR CALDER
IPC: A61F2/28
Filed: 2014-08-19
Abstract: This invention relates to and orthopaedic implant having an expansion means adapted to increase the external surface area of the implant, the expansion means positioned to correspond to voids or depressions in the anatomy of a patient. Also described are method for the design and manufacture of such implants.
Patent NZ-716007-A (NZ)
Title: Smoke alarm mounting and dismounting system and method
Inventor: LEATHERBY DARIN VINCENT
IPC: G08B17/00
Filed: 2014-04-24
Abstract: Smoke alarms require periodic access, such as for replacing batteries. As they are generally mounted on ceilings, gaining access can be difficult, particularly where ceilings are high. Accordingly, there is disclosed a method of mounting and dismounting a smoke alarm. The method includes the steps of providing a smoke alarm body adapted for detachable attachment to a supporting element mounted to an overhead surface such as a ceiling. The smoke alarm body defines an opening and the method includes the step of inserting an elongate implement into the opening. The method also includes applying a partial vacuum low air pressure force via the elongate implement so as to detach the smoke alarm body from the supporting element. In one application the elongate implement is a vacuum cleaner wand and it is employed to detach the smoke alarm body from a ceiling by a user standing on a floor surface below the ceiling.
Patent NZ-721311-A (NZ)
Title: Therapeutic methods and compositions
Inventor: THEZE JACQUES
IPC: C12N9/20
Filed: 2014-12-22
Abstract: The present invention relates to uses and products based on the finding that secreted Phospholipase A2 group IB (GIBsPLA2) is a factor in CD4 T-cell immunodeficiency, particularly in subjects with HIV. The claimed invention relates to use of inhibitors of GIBsPLA2 in preparing a medicament for treating a CD4 T-cell immunodeficiency where the inhibitor is anti-GIBsPLA2 antibody or derivative, soluble GIBsPLA2 receptor, inhibitory nucleic acid based on the GIBsPLA2 gene sequence, or a peptide of 3 to 20 amino acids obtained by selecting test peptides that inhibit GIBsPLA2. The claimed invention also relates to injectable pharmaceutical compositions comprising an inhibitory anti-GIBsPLA2 antibody or derivative and a carrier or excipient.
Patent NZ-733482-A (NZ)
Title: A pouch for tobacco with revertable pockets
Inventor: COOPER EDWARD
IPC: B65D85/07
Filed: 2016-01-15
Abstract: Disclosed is a pouch for tobacco with reversible pockets, to provide improved storage flexibility and improved opportunities for communication with the consumer. The pouch comprises a first pocket comprising a front wall, a back wall, a first opening and a flap formed by an elongated part of the back wall to close the first opening; a second pocket comprising a front wall, a back wall and a second opening; wherein the first and the second pocket are connected to each other along a reversible line such that the first pocket and the second pocket are foldable relative to each other along said reversible line in order to reversibly oppose the front walls of the first and second pocket or to oppose the back walls of the first and second pocket.
Patent NZ-738119-A (NZ)
Title: Radiotherapeutic particles and suspensions
Inventor: WESTRØM SARA
IPC: A61K103/00
Filed: 2016-07-01
Abstract: The present invention relates to a particle or pharmaceutical composition comprising one, more particles or a suspension of same or different particles comprising a degradable compound and an alpha emitting radionuclide and/or a radionuclide generating alpha emitting daughter. A particle comprising CaCO3, the alpha emitting radionuclide 224Ra, and a 224Ra radionuclide progeny is in particular disclosed. The particles are beneficial for use in the treatment of cancer.
Patent NZ-747808-A (NZ)
Title: Packing robot
Inventor: SCARFE ALISTAIR JOHN
IPC: B65B35/56
Filed: 2017-04-20
Abstract: A produce packing robot is provided comprising a plurality of heads for picking up items of produce from a plurality of pick-up locations, and moving the items of produce and dropping them off at a plurality of drop-off locations. The plurality of heads move together in a first direction on a common rail. The robot may also comprise a range imaging camera and controller for sensing the location of the drop- off points dynamically, and an orientation module, using the camera input, that indicates to the controller when an item of produce is nearly ready to be picked up, the controller then decides whether to wait for a nearly ready item to become ready, or move to the drop off zone.
Patent NZ-758548-A (NZ)
Title: Combination therapy including an mdm2 inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers
Inventor: CAENEPEEL SEAN
IPC: A61K31/437
Filed: 2014-11-11
Abstract: The present invention provides a combination therapy that includes the MDM2 inhibitor 2-((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid (AMG 232) or a pharmaceutically acceptable salt thereof with the additional pharmaceutically active agent cytarabine in the treatment of acute myelogenous leukemia (AML).
Patent NZ-760877-A (NZ)
Title: Terminal apparatus and core network device
Inventor: KAWASAKI Yudai
IPC: H04W28/24
Filed: 2018-06-19
Abstract: A User Equipment (UE) is provided to include a control unit configured to start a timer with a received back-off timer value; and a transmission and reception unit configured not to send another PDU SESSION ESTABLISHMENT REQUEST message without a network slice information until the timer expires, wherein the network slice information is Single-Network Slice Selection Assistance Information (S-NSSAI). A communication control method performed by a User Equipment (UE) is also provided to include starting a timer with a received back-off timer value; and not sending another PDU SESSION ESTABLISHMENT REQUEST message without a network slice information until the timer expires, wherein the network slice information is Single Network Slice Selection Assistance Information (S-NSSAI).
Patent PT-103738-A (PT)
Title: Processo biológico aeróbio de tratamento de efluentes agro-industriais com elevado teor em compostos aromáticos baseado na aplicação de microrganismos da espécie candida oleophila
Inventor: PERES JOSE ALCIDES SILVESTRE
IPC: C02F101/32
Filed: 2007-05-11
Abstract: A PRESENTE INVENÇÃO REFERE-SE A UM PROCESSO DE TRATAMENTO BIOLÓGICO AERÓBIO DE EFLUENTES AGRO-INDUSTRIAIS ATRAVÉS DA APLICAÇÃO DE LEVEDURAS DA ESPÉCIE CANDIDA OLEOPHÍLA, PERMITINDO A DEGRADAÇÃO BIOLÓGICA E TAMBÉM A DESCOLORAÇÃO DOS EFLUENTES, NOMEADAMENTE OS CONSTITUÍDOS POR UMA ELEVADA CARGA ORGÂNICA E UM ELEVADO TEOR DE COMPOSTOS AROMÁTICOS. DESTA FORMA, A PRESENTE INVENÇÃO TEM APLICAÇÃO NO TRATAMENTO DE EFLUENTES E ÁGUAS RESIDUAIS, EM PARTICULAR NA REDUÇÃO DE COMPOSTOS FENÓLICOS E ORGÂNICOS PRESENTES NESTE TIPO DE EFLUENTES.
Patent PT-104658-A (PT)
Title: Loção para tratamento de vitiligo e processo de produção da loção
Inventor: ROSARIO ANTONIO DO
IPC: A61K36/28
Filed: 2009-06-30
Abstract: O PRESENTE INVENTO DIZ RESPEITO À CRIAÇÃO DE UMA NOVA LOÇÃO TÓPICA PARA TRATAMENTO DE DOENÇA DE PELE DESIGNADA POR VITILIGO, CARACTERIZADA PELA PRESENÇA DE MANCHAS ACRÓMICAS (SEM PIGMENTAÇÃO) NA PELE, BEM COMO PELO RESPECTIVO PROCESSO DE PREPARAÇÃO. A NOVA LOÇÃO CARACTERIZA-SE PELA MISTURA DE EXTRACTOS DE PLANTAS NATURAIS (15 GRAMAS DE ABROTEA, 100 GRAMAS DE TASNEIRINHA E 25 GRAMAS DE SERRALHA), 1 LITRO DE ÁLCOOL ETÍLICO DE 70º VOLUME E 2 GRAMAS DE SULFATO. TODO O PROCESSO DE PREPARAÇÃO, DESDE A COLHEIRA, À SECAGEM E FILTRAGEM, É REALIZADO MANUALMENTE. NO FINAL, A LOÇÃO DEVE SER GUARDADA EM FRASCOS ESCUROS À TEMPERATURA AMBIENTE E FICA PRONTA A SER UTILIZADA.
Patent RO-91881-A (RO)
Inventor: SCHER HERBERT B
IPC: A01N25/28
Filed: 1985-03-28
Abstract: Novel microcapsules are disclosed in which a liquid material which is substantially insoluble in water is enclosed within a solid permeable shell of etherified urea-formaldehyde polymer, prepared by a process which comprises: (a) providing an organic solution comprising said material and a urea-formaldehyde prepolymer in which from about 50% to about 98% of the methylol groups of said prepolymer have been etherified with a C4-C10 alcohol; (b) creating an emulsion of said organic solution in an aqueous solution comprising water and a surface-active agent, wherein said emulsion comprises discrete droplets of said organic solution dispersed in said aqueous solution; (c) causing in situ self-condensation of said urea-formaldehyde prepolymers by adding to said emulsion an acidifying agent and maintaining said emulsion at a pH of between about 0 and about 4 for a sufficient period of time to allow substantial completion of in sttu condensation of said resin prepolymers to convert the liquid droplets of said organic solution to capsules consisting of solid permeable polymer shells enclosing said liquid material; and (d) heating said emulsion to a temperature between about 20 DEG C and about 100 DEG C to cause curing of said in situ formed polymers.
Patent RU-94011518-A (RU)
Inventor: KITAEV V B
IPC: G01M1/22
Filed: 1994-04-01
Abstract: FIELD: measurement technology. SUBSTANCE: invention refers to determination of disbalance of rotating mechanisms of cycle action. Essence of method involving measurement of period of rotation of part consists in processing of vibrosignal of rotating part. Rotation period is divided into n phase magnitudes relative to starting phase of cycle, in-phase magnitudes of vibrosignal for m periods are summed up. periodic component of vibrosignal is extracted as function of turning angle of rotating part relative to starting phase. Then Fourier transform of extracted periodic component is performed and amplitude and phase of first harmonic are found and used to evaluate disbalance value and angle. EFFECT: improved authenticity of method, increased precision of measurement of amplitude and disbalance angle under conditions of heavy vibrational noises and diminished number of components of equipment used for realization of method. 1 cl
Patent RU-94024330-A (RU)
Inventor: KARJAKINA E V
IPC: G01N33/50
Filed: 1994-06-29
Abstract: FIELD: clinical biochemistry. SUBSTANCE: process consists in proteolysis of comminuted sample with papain, deproteinization of hydrolyzate with trichlorophenoxyacetic acid and in precipitation of clycosoaminoglycans with ethanol carrying acidic salts of potassium or sodium. Novelty of process lies in performance of proteolysis with continuous agitation of sample in 0.05-0.0 M acetate buffer containing papain in the amount of one fifth of wet weight of tissue at temperature + 60<$E+->4 C in the course of 1.5-2.0 h. Deproteininzation of obtained hydrolyzate and precipitation of glycosoaminoglycans with ethanol are carried out in the course of 1.5-2.0 h at temperature (-10)-(-20) C per each stage. EFFECT: 2-3 days reduction of procedure of extraction of glycosoaminoglycans from fibrous cartilage.
Patent RU-94030534-A (RU)
Inventor: SABEL NIKOVA T A
IPC: A23B4/044
Filed: 1994-08-05
Abstract: FIELD: food industry. SUBSTANCE: products for smoking are cured in composition for meat injection in which except salt, spices and other components, extract of onion peels is introduced in amount of 0.5-5% mas.% from composition mass. Then smoking is carried out by smoke, steam-smoke or liquid components. EFFECT: stable and uniform color of smoked products. 1 cl
Patent RU-94033539-A (RU)
Inventor: KAPTSOV V V
IPC: C07K14/215
Filed: 1994-09-12
Abstract: FIELD: microbiology; methods for separation of proteis, particularly, bacteriorhodopsin contained in purpuric membranes of microorganisms of species HALOBACTERIUM HALOBIUM; may be used in biotechnology and photochemical and electronic industries, scientific research practice in study of photo- and electrochromic conversions, and also for preparation of biologic photorecording material of repeated use. SUBSTANCE: method for production of purpuric membrane fragments sizing from 50 to 400 nm and containing bacteriorhodopsin provides for separation of purpuric membranes from biomass of hallophyllic bacteria by the method of cyclic extrusion at pressure of 150 MPa in 1 to 5 cycles and subsequent procedure of centrifuging and washing out in bidistilled water with 25000-100000 g for 30 min, each procedure is continued until relation of optical densities of suspension of purpuric membrane fragments with wave lengths of 280 nm and 560 nm becomes equal to 1.9 to 2.1, In so doing, a version is possible when procedure of centrifuging and washing in bidistilled water is accomplished in two stages, first with 25000 g for 30 min and then, with 100000 g for 30 min, alternately. Prior to disintegration biomass is placed in bidistillate in concentration about 100 wt.-%, and after mixing is passed through homogenizing valve of special design at invariable preset pressure. Bacteriorhodopsin yield is not less than 1 g from 100 g of biomass, or 40 l of cultural suspension of cells of halobasteria. EFFECT: increased efficiency of the process with simultaneous lowering of price; provision of regulated reduction of average size of particles of fragment of purpuric membranes containing bacteriorhodopsin and standard deviation of their distribution in sizes.